https://pacira.com

Transforming how the world treats pain – Pacira BioSciencesBetter is possible. Join us in reimagining pain management with innovative, non-opioid therapies for chronic, postsurgical and musculoskeletal pain.Transforming how the world treats pain – Pacira BioSciences Share your story Sustainability Partnerships News Medical Information Company About us Leadership Impact Therapies Reimagining pain relief EXPAREL ZILRETTA Innovation Pipeline PCRX-201 PCRX-2002 Clinical trials pMVL technology Patients Explore insights Patient Voices Understand pain Plan ahead For Caregivers Careers Life at Pacira Benefits Open positions Investors Overview Events SEC filings Analyst coverage Corporate governance Investor toolkit Investor FAQ Share your story Sustainability Partnerships News Medical Information Search Button Search Better Pain Management is Possible Better Pain Management is Possible More than 18 million patients have been treated with Pacira non-opioid therapies. We are building on that foundation every day. Our goal is to expand treatment options and partner across healthcare to make non-opioid therapies the standard, not the exception. Leading with science Our commercial portfolio spans postsurgical, chronic, and musculoskeletal pain. Our pipeline includes a gene therapy candidate for knee osteoarthritis. Our therapies Patients at the center Pain affects every part of life. We help patients understand their options and advocate for non-opioid care with their providers. Your path to relief Mission-driven Pacira was built on the belief that patients deserve better options. Our team works across science, education and advocacy to make that real. Our impact Science that refuses to settle Our commercial therapies address postsurgical, chronic, and musculoskeletal pain. Our investigational pipeline includes PCRX-201, a gene therapy candidate for knee osteoarthritis, and is poised to transform how we approach osteoarthritis treatment with the goal of helping patients return to normal function. We remain committed to advancing therapies backed by rigorous, peer-reviewed clinical evidence. Learn about our therapies Explore our pipeline Empowering shared decision-making Better conversations lead to better care. We equip patients and caregivers with the resources to explore non-opioid options and partner with their providers on a plan built around them. View resources Partnering to advance access, education, and advocacy Expanding access to non-opioid options requires working across the full healthcare system, with providers, policymakers, and patient advocates. More than 40 million people now have coverage for post surgical pain therapies and outpatient surgeries through commercial and governmental plans including the NOPAIN act. We are committed to continuing that progress. Learn about our impact Join us in making a difference Our teams are united by a passion for excellence and a commitment to patients. Here, you can grow your career while making a real impact. See career opportunities Pacira LinkedIn X YouTube Instagram Facebook Share your story Share your story EXPAREL® (bupivacaine liposome injectable suspension), ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), and Pacira are registered trademarks of the respective subsidiaries of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners. Contact Health Data Privacy Policy Sitemap Privacy Policy Terms of Use Accessibility Statement Medical Information © 2026 Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc. PP-MP-US-0289 The Pacira website is intended for U.S. residents only. Are you a U.S. resident? Yes No You are now leaving Pacira.com Stay on Pacira.com Continue to external site × × ×enenhttps://pacira.com

Edit your site?

What are you doing?